Biotech Values

[RNsidersbuying]

NVAX 16.84 - reentered on the dip in afterhours. Looks to be a lock to eventually proceed to the final "six to eight" vaccine trials in Operation Warp Speed.

1. NVAX was an attendee at the 3/2/20 WH Meeting.

2. Recent "Nanovax" Phase-3 success:

https://finance.yahoo.com/news/novavax-nanoflu-achieves-primary-endpoints-100010015.html

3. NVX-CoV2373 coronavirus vaccine 'in-human' trials scheduled to start mid-May:

https://finance.yahoo.com/news/novavax-identifies-coronavirus-vaccine-candidate-100010906.html